South Korea · Delayed Price · Currency is KRW Ildong Pharmaceutical Statistics
Total Valuation
KRX:249420 has a market cap or net worth of KRW 894.83 billion. The enterprise value is 1.04 trillion.
| Market Cap | 894.83B |
| Enterprise Value | 1.04T |
Important Dates
The last earnings date was Thursday, October 30, 2025.
| Earnings Date | Oct 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
KRX:249420 has 31.51 million shares outstanding. The number of shares has increased by 1.19% in one year.
| Current Share Class | 31.51M |
| Shares Outstanding | 31.51M |
| Shares Change (YoY) | +1.19% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 2.11% |
| Owned by Institutions (%) | 3.07% |
| Float | 20.60M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.53 |
| PB Ratio | 5.34 |
| P/TBV Ratio | 6.55 |
| P/FCF Ratio | 135.03 |
| P/OCF Ratio | 55.12 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 26.03, with an EV/FCF ratio of 156.72.
| EV / Earnings | -418.54 |
| EV / Sales | 1.77 |
| EV / EBITDA | 26.03 |
| EV / EBIT | 67.70 |
| EV / FCF | 156.72 |
Financial Position
The company has a current ratio of 0.79, with a Debt / Equity ratio of 1.24.
| Current Ratio | 0.79 |
| Quick Ratio | 0.40 |
| Debt / Equity | 1.24 |
| Debt / EBITDA | 5.18 |
| Debt / FCF | 31.40 |
| Interest Coverage | 1.02 |
Financial Efficiency
Return on equity (ROE) is -5.73% and return on invested capital (ROIC) is 2.55%.
| Return on Equity (ROE) | -5.73% |
| Return on Assets (ROA) | 1.64% |
| Return on Invested Capital (ROIC) | 2.55% |
| Return on Capital Employed (ROCE) | 5.67% |
| Revenue Per Employee | 549.34M |
| Profits Per Employee | -2.33M |
| Employee Count | 1,067 |
| Asset Turnover | 0.99 |
| Inventory Turnover | 3.80 |
Taxes
| Income Tax | -4.20B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +110.06% in the last 52 weeks. The beta is 1.07, so KRX:249420's price volatility has been similar to the market average.
| Beta (5Y) | 1.07 |
| 52-Week Price Change | +110.06% |
| 50-Day Moving Average | 24,704.00 |
| 200-Day Moving Average | 16,371.15 |
| Relative Strength Index (RSI) | 60.96 |
| Average Volume (20 Days) | 3,138,266 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:249420 had revenue of KRW 586.15 billion and -2.48 billion in losses. Loss per share was -88.84.
| Revenue | 586.15B |
| Gross Profit | 221.37B |
| Operating Income | 15.59B |
| Pretax Income | -13.92B |
| Net Income | -2.48B |
| EBITDA | 40.15B |
| EBIT | 15.59B |
| Loss Per Share | -88.84 |
Balance Sheet
The company has 68.54 billion in cash and 208.09 billion in debt, giving a net cash position of -139.55 billion or -4,429.07 per share.
| Cash & Cash Equivalents | 68.54B |
| Total Debt | 208.09B |
| Net Cash | -139.55B |
| Net Cash Per Share | -4,429.07 |
| Equity (Book Value) | 167.44B |
| Book Value Per Share | 5,843.09 |
| Working Capital | -64.98B |
Cash Flow
In the last 12 months, operating cash flow was 16.23 billion and capital expenditures -9.61 billion, giving a free cash flow of 6.63 billion.
| Operating Cash Flow | 16.23B |
| Capital Expenditures | -9.61B |
| Free Cash Flow | 6.63B |
| FCF Per Share | 210.33 |
Margins
Gross margin is 37.77%, with operating and profit margins of 2.66% and -0.42%.
| Gross Margin | 37.77% |
| Operating Margin | 2.66% |
| Pretax Margin | -2.37% |
| Profit Margin | -0.42% |
| EBITDA Margin | 6.85% |
| EBIT Margin | 2.66% |
| FCF Margin | 1.13% |
Dividends & Yields
KRX:249420 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.19% |
| Shareholder Yield | -1.19% |
| Earnings Yield | -0.28% |
| FCF Yield | 0.74% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 5, 2020. It was a forward split with a ratio of 1.05.
| Last Split Date | Mar 5, 2020 |
| Split Type | Forward |
| Split Ratio | 1.05 |
Scores
KRX:249420 has an Altman Z-Score of 1.63 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.63 |
| Piotroski F-Score | 6 |